An Innovative Australian Outreach Model of Diabetic Retinopathy Screening in Remote Communities

Journal of Diabetes Research
Nicola M GlassonSarah L Larkins

Abstract

Background. Up to 98% of visual loss secondary to diabetic retinopathy (DR) can be prevented with early detection and treatment. Despite this, less than 50% of Australian and American diabetics receive appropriate screening. Diabetic patients living in rural and remote communities are further disadvantaged by limited access to ophthalmology services. Research Design and Methods. DR screening using a nonmydriatic fundal camera was performed as part of a multidisciplinary diabetes service already visiting remote communities. Images were onforwarded to a distant general practitioner who identified and graded retinopathy, with screen-positive patients referred to ophthalmology. This retrospective, descriptive study aims to compare the proportion of remote diabetic patients receiving appropriate DR screening prior to and following implementation of the service. Results. Of the 141 patients in 11 communities who underwent DR screening, 16.3% had received appropriate DR screening prior to the implementation of the service. In addition, 36.2% of patients had never been screened. Following the introduction of the service, 66.3% of patients underwent appropriate DR screening (p = 0.00025). Conclusion. This innovative model has greatly im...Continue Reading

References

Jun 18, 1998·Australian and New Zealand Journal of Ophthalmology·C A HarperH R Taylor
Jun 26, 1998·The British Journal of Ophthalmology·C A McCartyH R Taylor
Sep 14, 1999·Australian and New Zealand Journal of Ophthalmology·S J LeeJ E Keeffe
Jul 25, 2000·The British Journal of Ophthalmology·R McKayH R Taylor
Sep 12, 2000·Clinical & Experimental Ophthalmology·S J LeeJ E Keeffe
Oct 18, 2000·Ophthalmic Epidemiology·S J LeeJ E Keeffe
Sep 6, 2002·Clinical & Experimental Ophthalmology·Anna C MaddenHugh R Taylor
Jul 16, 2003·Acta Ophthalmologica Scandinavica·Lalit VermaNisha Sharma
Oct 1, 2003·Clinical & Experimental Ophthalmology·Daniel J McCartyCatherine A McCarty
Dec 3, 2003·The Australian Journal of Rural Health·Donna B MakIan McAllister
May 18, 2005·The Medical Journal of Australia·Richard B MurrayIan L McAllister
Aug 25, 2006·Journal of Visual Communication in Medicine·Chris J BarryYogesan Kanagasingam
Aug 23, 2007·JAMA : the Journal of the American Medical Association·Quresh MohamedTien Y Wong
Nov 14, 2007·Clinical & Experimental Ophthalmology·Zoran GeorgievskiIgnatios Koukouras
Nov 22, 2007·Expert Opinion on Therapeutic Targets·Raymond M SchiffelersGert Storm
Feb 28, 2009·Journal of Telemedicine and Telecare·Riku Lemmetty, Kari Mäkelä
Mar 2, 2010·Diabetes Research and Clinical Practice·Pedro RomeroMarc Baget
Jul 21, 2010·Australian and New Zealand Journal of Public Health·Geoffrey K P SpurlingClaire L Jackson
May 12, 2012·Contemporary Clinical Trials·Deborah A AskewClaire L Jackson
Jun 26, 2012·Current Diabetes Reports·Tunde Peto, Christine Tadros
Apr 9, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sheena McHughDiarmuid Quinlan
Sep 28, 2013·Ophthalmic Epidemiology·Christopher B EstopinalJeremy D Keenan

❮ Previous
Next ❯

Citations

Jan 30, 2018·Asia-Pacific Journal of Ophthalmology·Jacqueline ChuaCharumathi Sabanayagam
Nov 1, 2016·Current Diabetes Reports·Mark B HortonLloyd Paul Aiello
Nov 1, 2016·Current Diabetes Reports·Mark B HortonLloyd Paul Aiello
Aug 29, 2020·Translational Vision Science & Technology·David LeXincheng Yao
Oct 30, 2020·Clinical Ophthalmology·Elizabeth Pearce, Sobha Sivaprasad

❮ Previous
Next ❯

Software Mentioned

RODRS
Excel
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.